Athersys (ATHX) Prices 22.25M Share Common Offering at $2.25/Sh

Athersys, Inc. (NASDAQ: ATHX) (Athersys) today announced the pricing of its previously announced underwritten public offering of its common stock, par value $0.001 per share (Common Stock), at a price to the public of $2.25 per share, for a total of 22,250,000 shares. Gross proceeds to Athersys from the offering are expected to be approximately $50.1 million, before deducting the underwriting discount and estimated offering expenses. In connection with the offering, Athersys has granted the underwriters a 30-day option to purchase up to an additional 3,337,500 shares of Common Stock from Athersys at the public offering price (less the underwriting discount). The offering is expected to close on April 20, 2020, subject to customary closing conditions.

BofA Securities is acting as sole book-running manager for the offering. Needham & Company, SMBC and WBB Securities are acting as co-managers for the offering.

Athersys intends to use the net proceeds from the offering for working capital and general corporate purposes, including funding towards its acute respiratory distress syndrome (ARDS) clinical program, which includes initiation of a Phase 2/3 pivotal study for COVID-19 induced ARDS patients, referred to as the MACOVIA study, and its process development and manufacturing projects.

You May Also Be Interested In

• Needham says State AGs delay on Paramount Skydance (PSKY) deal 'will NOT derail the deal'
• SOBRsafe raises $3.1M through warrant exercise at reduced price
• Needham Starts Park Electrochemical (PKE) at Buy